Point cloud fusion instance effect. حسب Hongliang Zou (20707270)

الموضوعات:

HDECO: A method for Decreasing energy and cost by using virtual machine migration by considering hybrid parameters حسب Arash GhorbanniaDelavar (22563696)

"…<h2>Summary</h2><p dir="ltr">This research introduces <b>HDECO</b> (Hybrid Decreasing Energy and Cost Optimization) — a method designed to reduce both energy consumption and execution cost in cloud datacenters through intelligent virtual machine migration. …"

The technical route of the study. حسب Hongliang Zou (20707270)

الموضوعات:

Experimental results in the SubT-MRS dataset. حسب Hongliang Zou (20707270)

الموضوعات:

Schematic diagram of time stamp synchronization between LIDAR and camera in a multi-sensor system. حسب Hongliang Zou (20707270)

الموضوعات:

Positioning errors of different algorithms on the a multi-modal and multi-scenario dataset for ground robots dataset. حسب Hongliang Zou (20707270)

الموضوعات:

Specific parameters of the test sequence in the a multi-modal and multi-scenario dataset for ground robots dataset. حسب Hongliang Zou (20707270)

الموضوعات:

Thematic clouds for lectures. حسب Ignacio García-Espona (21395335)

Displacement cloud maps. حسب Maogang Tian (21485116)

Sampling point (Source: حسب Yonggang Huang (223155)

Thematic cloud for posters [2013-23]. حسب Ignacio García-Espona (21395335)

Data Sheet 1_An autonomous navigation method for orchard mobile robots based on octree 3D point cloud optimization.docx حسب Hailong Li (216327)

"…However, the increased richness of information provided by 3D LiDAR also leads to a higher computational burden for point cloud data processing, posing challenges to real-time navigation. …"

Content analysis of groups with decreased confidence. حسب Yasutaka Yanagita (11105508)

PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. حسب Katherine Schubert (5452712)

The energy density of peak point with different freezing temperatures. حسب Liang Zhang (41392)

Table 5_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

"…An increasing amount of research points to a connection between COPD and NAFLD. This study aimed to identify the key genes of these two diseases, construct a diagnostic model, and predict potential therapeutic agents based on critical genes.…"

Table 1_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

"…An increasing amount of research points to a connection between COPD and NAFLD. This study aimed to identify the key genes of these two diseases, construct a diagnostic model, and predict potential therapeutic agents based on critical genes.…"

Table 4_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

"…An increasing amount of research points to a connection between COPD and NAFLD. This study aimed to identify the key genes of these two diseases, construct a diagnostic model, and predict potential therapeutic agents based on critical genes.…"

Table 3_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

"…An increasing amount of research points to a connection between COPD and NAFLD. This study aimed to identify the key genes of these two diseases, construct a diagnostic model, and predict potential therapeutic agents based on critical genes.…"

Table 6_Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.xlsx حسب Jianwei Hong (6918776)

"…An increasing amount of research points to a connection between COPD and NAFLD. This study aimed to identify the key genes of these two diseases, construct a diagnostic model, and predict potential therapeutic agents based on critical genes.…"